Cargando…
New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization
Vaccinia virus (VACV) is a promising oncolytic agent because it exhibits many characteristic features of an oncolytic virus. However, its effectiveness is limited by the strong antiviral immune response induced by this virus. One possible approach to overcome this limitation is to develop deimmunize...
Autores principales: | Khlusevich, Yana, Matveev, Andrey, Emelyanova, Lyudmila, Goncharova, Elena, Golosova, Natalia, Pereverzev, Ivan, Tikunova, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227246/ https://www.ncbi.nlm.nih.gov/pubmed/35746695 http://dx.doi.org/10.3390/v14061224 |
Ejemplares similares
-
New Neutralizing Epitope Exposed on the Domain II of Tick-Borne Encephalitis Virus Envelope Glycoprotein E
por: Matveev, Andrey, et al.
Publicado: (2023) -
Design and Engineering of Deimmunized Vaccinia Viral Vectors
por: Song, Kevin, et al.
Publicado: (2020) -
Novel mouse monoclonal antibodies specifically recognize Aspergillus fumigatus galactomannan
por: Matveev, Andrey L., et al.
Publicado: (2018) -
Antibodies Capable of Enhancing SARS-CoV-2 Infection Can Circulate in Patients with Severe COVID-19
por: Matveev, Andrey, et al.
Publicado: (2023) -
Deimmunization of protein therapeutics – Recent advances in experimental and computational epitope prediction and deletion
por: Zinsli, Léa V., et al.
Publicado: (2020)